Cargando…
The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics
The effect of the cytochrome P450 oxidoreductase (POR) rs10954732 (G > A) polymorphism on hepatocellular carcinoma (HCC) susceptibility is unknown. Here we found that A allele carriers showed a 69% decrease in susceptibility to HCC with overall survival (OS) prolonged to 199%, accompanied by lowe...
Autores principales: | Fang, Yan, Yang, Hongming, Hu, Guiming, Lu, Jiakun, Zhou, Jun, Gao, Na, Gu, Yuhan, Zhang, Cunzhen, Qiu, Jinhuan, Guo, Yuanyuan, Zhang, Yunfei, Wen, Qiang, Qiao, Hailing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842912/ https://www.ncbi.nlm.nih.gov/pubmed/35164791 http://dx.doi.org/10.1186/s12967-022-03282-1 |
Ejemplares similares
-
Use of proteomics to identify mechanisms of hepatocellular carcinoma with the CYP2D6*10 polymorphism and identification of ANGPTL6 as a new diagnostic and prognostic biomarker
por: Hu, Guiming, et al.
Publicado: (2021) -
Identification of Cytochrome P450 2E1 as a Novel Target in Glioma and Development of Its Inhibitor as an Anti‐Tumor Agent
por: Hu, Guiming, et al.
Publicado: (2023) -
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells
por: Rodenas, Maria Carmen, et al.
Publicado: (2023) -
The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma
por: Gu, Yuhan, et al.
Publicado: (2022) -
High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016)